Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2026-02-02 @ 7:20 AM
Study NCT ID:
NCT00776802
Status:
WITHDRAWN
Last Update Posted:
2013-06-25
First Post:
2008-10-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
GCS-100LE in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sponsor:
La Jolla Pharmaceutical Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PR-CS010
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None